| MeSH term | MeSH ID | Detail |
|---|---|---|
| Birth Weight | D001724 | 23 associated lipids |
| Bites, Human | D001734 | 2 associated lipids |
| Blister | D001768 | 16 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Boutonneuse Fever | D001907 | 5 associated lipids |
| Bronchiolitis | D001988 | 6 associated lipids |
| Bronchiolitis Obliterans | D001989 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Carcinoma, Basal Cell | D002280 | 6 associated lipids |
| Carcinoma, Squamous Cell | D002294 | 14 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zheng H et al. | Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure. | 2015 | Sex Transm Dis | pmid:25668641 |
| Hublikar S et al. | Disseminated gonococcal infection and eculizumab--a "high risk" connection? | 2014 | Sex Transm Dis | pmid:25581812 |
| Cole MJ et al. | Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe. | 2014 | Sex Transm Dis | pmid:25581808 |
| Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in Treponema pallidum in the United States, 2007 to 2009. | 2012 | Sex Transm Dis | pmid:23001267 | |
| Starnino S et al. | Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. | 2012 | Sex Transm Dis | pmid:23001269 |
| Thakur SD et al. | Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011. | 2017 | Sex Transm Dis | pmid:28178114 |
| Asbel LE et al. | School-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae among Philadelphia public high school students. | 2006 | Sex Transm Dis | pmid:16614587 |
| Katz KA et al. | Molecular epidemiology of syphilis--San Francisco, 2004-2007. | 2010 | Sex Transm Dis | pmid:20601928 |
| Lavoué V et al. | Screening for Chlamydia trachomatis using self-collected vaginal swabs at a public pregnancy termination clinic in France: results of a screen-and-treat policy. | 2012 | Sex Transm Dis | pmid:22801345 |
| Holman KM et al. | Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy. | 2012 | Sex Transm Dis | pmid:22801348 |
| Bornstein M et al. | Factors Associated With Primary Care Physician Knowledge of the Recommended Regimen for Treating Gonorrhea. | 2017 | Sex Transm Dis | pmid:27898574 |
| Tapsall JW et al. | Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. | 1998 | Sex Transm Dis | pmid:9858344 |
| Farley TA et al. | The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention. | 2003 | Sex Transm Dis | pmid:14603093 |
| Peters RP et al. | Gonococcal Conjunctivitis Despite Successful Treatment of Male Urethritis Syndrome. | 2016 | Sex Transm Dis | pmid:26760182 |
| Gratrix J et al. | A Retrospective Review of Treatment Failures Using Azithromycin and Doxycycline in the Treatment of Rectal Chlamydia Infections in Women and Men Who Have Sex With Men. | 2016 | Sex Transm Dis | pmid:26760180 |
| Blandford JM and Gift TL | The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. | 2003 | Sex Transm Dis | pmid:12782951 |
| Dillon JA et al. | Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent. | 2001 | Sex Transm Dis | pmid:11518867 |
| Dillon JA et al. | Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. | 2001 | Sex Transm Dis | pmid:11518869 |
| SteingrÃmsson O et al. | Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. | 1994 Jan-Feb | Sex Transm Dis | pmid:8140488 |
| Yuan LF et al. | Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. | 2011 | Sex Transm Dis | pmid:21844727 |
| Boix V et al. | Polyostotic osteitis in secondary syphilis in an HIV-infected patient. | 2013 | Sex Transm Dis | pmid:23859912 |
| Khosropour CM et al. | Comparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: a retrospective cohort study. | 2014 | Sex Transm Dis | pmid:24413484 |
| Jordan SJ and Geisler WM | Azithromycin for rectal chlamydia: is it time to leave azithromycin on the shelf?...Not yet. | 2014 | Sex Transm Dis | pmid:24413485 |
| Lau CY and Qureshi AK | Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. | 2002 | Sex Transm Dis | pmid:12218839 |
| Singh AE et al. | Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013. | 2015 | Sex Transm Dis | pmid:25970311 |
| Nieuwenhuis RF et al. | Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin. | 2003 | Sex Transm Infect | pmid:14663119 |
| Niccolai LM et al. | Behavioural sources of repeat Chlamydia trachomatis infections: importance of different sex partners. | 2011 | Sex Transm Infect | pmid:21212380 |
| Bowden FJ and Savage J | Azithromycin for the treatment of donovanosis. | 1998 | Sex Transm Infect | pmid:9634320 |
| Khosropour CM et al. | Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial. | 2015 | Sex Transm Infect | pmid:25616607 |
| Magbanua JP et al. | Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests: molecular characterisation and failure of single dose azithromycin. | 2007 | Sex Transm Infect | pmid:17567684 |
| Gundevia Z et al. | Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort. | 2015 | Sex Transm Infect | pmid:25096921 |
| National guideline for the management of donovanosis (granuloma inguinale). Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). | 1999 | Sex Transm Infect | pmid:10616381 | |
| Pasternack R et al. | Follow up of treatment: an integral part of the control of Chlamydia trachomatis infections. | 1999 | Sex Transm Infect | pmid:10448353 |
| Romoren M et al. | Costs and health consequences of chlamydia management strategies among pregnant women in sub-Saharan Africa. | 2007 | Sex Transm Infect | pmid:17932126 |
| Björnelius E et al. | macrolide resistance in Stockholm, Sweden. | 2017 | Sex Transm Infect | pmid:27502694 |
| Horner PJ | Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. | 2012 | Sex Transm Infect | pmid:22416272 |
| Thompson C | Azithromycin v oxytetracycline for the treatment of non-specific urethritis. | 2000 | Sex Transm Infect | pmid:10961211 |
| Hathorn E et al. | What is the most appropriate treatment for rectal Chlamydia trachomatis infection? | 2016 | Sex Transm Infect | pmid:26892930 |
| Bartelsman M et al. | Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam. | 2014 | Sex Transm Infect | pmid:24860102 |
| Hathorn E et al. | What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women? | 2012 | Sex Transm Infect | pmid:22517887 |
| Murray S and Marshall L | Empiric NSU treatment needs updating. | 2014 | Sex Transm Infect | pmid:25028712 |
| Oud EV et al. | Pitfalls in the diagnosis and management of inguinal lymphogranuloma venereum: important lessons from a case series. | 2014 | Sex Transm Infect | pmid:24787368 |
| Gayet-Ageron A et al. | Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples. | 2009 | Sex Transm Infect | pmid:19155240 |
| Chisholm SA et al. | An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England. | 2016 | Sex Transm Infect | pmid:26601852 |
| Ito S et al. | Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. | 2011 | Sex Transm Infect | pmid:21653933 |
| Fifer H et al. | Gonorrhoea treatment position statement. | 2015 | Sex Transm Infect | pmid:26195472 |
| Khosropour CM et al. | Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study. | 2014 | Sex Transm Infect | pmid:24106340 |
| Horner P and Saunders J | Should azithromycin 1 g be abandoned as a treatment for bacterial STIs? The case for and against. | 2017 | Sex Transm Infect | pmid:27418572 |
| Horner P | The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. | 2006 | Sex Transm Infect | pmid:16877590 |
| Rice LB | Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae? | 2015 | Sex Transm Infect | pmid:25926405 |